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Abstract
Mitochondrial dysfunction plays a vital role in the progression of Parkinson’s 
Disease (PD) via inducing activation of Caspases and Caspase cascade. This 
review focuses on the mitochondrial intrinsic pathway involved in Caspase 
activation and its participation in PD progression. Oxidative stress, ER stress, 
environmental toxins, alongside genetic mutations and excitotoxicity can 
stimulate activation of different pathways including inflammatory, JNK, NFĸB 
and p38 leading to mitochondrial dysfunction and the release of cytochrome C. 
Subsequently, this leads to the activation of initiator Caspases (-2, -8, -9 and 
-10), followed by the activation of executioner Caspases (-3, -6 and -7), resulting 
in dopaminergic cell death and development of PD. This review summarises and 
updates the most recent findings related to the activation of specific Caspases 
via different routes focusing on the mitochondrial intrinsic pathway that leads to 
the destruction of dopaminergic neurons resulting in PD pathogenesis.
Keywords: Parkinson’s disease; Caspase; Cascade mitochondria; 
Oxidative stress; Cytochrome C
Pore (mPTP) of the mitochondria leading to the collapse of the 
mitochondrial membrane potential and the release of cytochrome C. 
Furthermore, increased ROS activity promote nitric oxide binding 
to superoxide producing peroxynitrate enhancing oxidative and 
nitrosative stress, which results in DNA damage, chromosomal 
mutations, lipid peroxidation and enzyme defects [3]. Mutation of 
E3 ligase caused by peroxynitrate damage leads to impairment of 
ubiquitin-proteasome system, resulting in high levels of defective 
proteins, which accumulate in the Endoplasmic Reticulum (ER) 
promoting ER stress and ultimately cell death. Moreover, the apoptotic 
neuron triggers injury signals that activate microglia and promote 
release of cytokines such as interleukins-6 and -8. Subsequently, 
interleukins trigger Caspase activation along with inducible NO 
synthase, which further elevates formation of nitric oxide. Exposure 
to excessive reactive nitrite species along with enhanced production 
of ROS and peroxynitrate lead to dysfunction of complex-IV and 
complex-I activities of the mitochondria and promote mitochondrial-
mediated apoptosis through Caspase activation [4,5].
Caspases and Parkinson’s disease
The loss of DCN within the basal ganglia has been strongly 
associated with the activation of Caspases (Caspase1-14), a family of 
cysteine proteases [6-8]. The stimulation of various pathways such 
as oxidative stress, inflammation, ER stress and toxins promote 
activation of different Caspases via intrinsic or extrinsic routes, such 
as mitochondrial or Nuclear Factor Kappa B (NFκB) respectively, 
leading to death of DCN and PD onset [9]. Caspases can be categorized 
into two main types; initiator Caspases and executioner Caspases as 
upstream and downstream respectively. The difference is based on 
their attributes, such as the role of action and participation in the 
proteolytic Caspase cascade. Initiator Caspases (Caspase-2,-8,-9 and 
-10) have long prodomains, which permit joining of proteases to their 
specific activators [10,11]. Initiator Caspases can activate executioner 
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Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder 
characterised by tremor, rigidity, Bradykinesia and reduced facial 
expression. Development of PD is considered to be the result of 
deficiency of the neurotransmitter dopamine, which is due to death 
of Dopamine-Containing Neurons (DCNs) that produce dopamine 
in the pars compacta region of the substantia nigra. Although 
the concentrated efforts of the scientific community over the last 
decades, the etiology of the death of DCN is yet to be understood. 
Oxidative stress has been considered as one of the causes of defects 
in the mitochondria leading to the dopaminergic cell damage [1]. 
Levodopa therapy is a well-known treatment for the symptoms of PD, 
however long term use of L-dopa causes side effects including further 
enhancement of oxidative stress [2]. The elevated levels of Reactive 
Oxidative Species (ROS) such as hydrogen peroxide, superoxide and 
hydroxyl ions, induce stimulation to the Permeability Transition 
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Caspases (Caspase-3, -6and -7), resulting in death of cells via apoptotic 
routes (Figure1). Caspase-2 is a unique member of the family as it 
possesses a dual function, either promoting or suppressing cell death. 
Moreover, Caspases are able to cleave and activate other members 
of the Caspase family. An imbalance between active pro-apoptotic 
and anti-apoptotic proteins results in the development of pathogens 
is contributing to apoptosis of DCN that leads to onset of PD [6,10].
The protein, α-synuclein is abundantly found in presynaptic 
terminals of neurons and in cerebrospinal fluid. It plays a vital role 
in synaptic maturation and neuronal plasticity. A study conducted 
by Tai et al (2014) suggested that ROS promote the production of 
α-synuclein in protein inclusions, contributing to the pathogenesis 
of PD [12]. Moreover, Smith et al (2005) revealed that mutant 
α-synuclein can elevate levels of Caspases -3, -9 and -12 along with 
ROS in differentiated PC12 cells [13]. The mutant α-synuclein has 
been shown to participate in both ER stress and mitochondrial 
dysfunction pathways. ER stress stimulates the Unfolded Stress 
Response (USR), enabling an ER transmembrane kinase PERK 
(protein kinase RNA-like endoplasmic reticulum kinase) to activate 
Caspase-12. Subsequently, Caspase-12 activates Caspase-9, followed 
by stimulation of Caspase-3, resulting in cell death. The α-synuclein 
combined with mitochondrial impairment interferes with the 
transport of dopamine contributing to apoptosis and cell destruction. 
Further support for this view has come from a study conducted by 
Mizuno and colleagues, which suggested that nigral death, could be 
the result of elevated levels of oxidative stress and respiratory failure 
of the mitochondria [5]. Substantial increases of damage in DNA, 
protein and lipid caused by ROS and oxidative stress has been found 
in PD patients. In vitro and in vivo models of PD confirm increased 
DNA fragmentation in DCN via induction of Caspase-3 activity [6].
Research by Liou et al (2005) has found a significant rise of 
Caspases-9, -3 and Calpain activities in MPTP-treated PC12 cells [14]. 
Calpain is a cytosolic calcium-activated protease, which provokes 
cleavage and release of Apoptosis-Inducing Factor (AIF) from the 
mitochondria into the cytosol. AIF adhered to the mitochondrial 
surface upon entering into the cytosol and promote the release of 
cytochrome C leading to activation of Caspases-9 and -3 resulting in 
dopaminergic cell death. Similarly, DNA fragmentation, chromatin 
condensation and presence of apoptotic bodies have been found in 
dopaminergic MN9D cells supporting the evidence that dopaminergic 
cell death follows a mitochondrial-dependent apoptotic pathway. The 
enhanced release of cytochrome C, alongside impaired ATP levels, 
encourages the production of ROS, which contributes to further cell 
death [15].
Caspase-3 catabolises proteins that constitute the cytoskelatal 
structure, fodrin and actin, resulting in loss of cellular shape alongside 
loss of cellular adhesion, and contributing to the decrease in cell 
volume and production of apoptotic bodies. Moreover, Caspase-3 
activates Caspases-6 and -7, which play a vital role in cell apoptosis 
via digestion of specific cellular structures (Figure 2). Caspase-6 
promotes the digestion of fibrous proteins, which are essential to 
nuclear structure and function, such as lamins, causing nuclear 
shrinkage and budding of the cell, and resulting in the formation of 
apoptotic bodies. While, Caspase-7 inhibits DNA repair by digesting 
poly ADP-ribose Polymerase-1(PARP), Caspase-3 catabolises the 
DNA repair enzyme DNA dependent Protein Kinase (DNA-PK) into 
fragments, thereby preventing the cell to repair itself leading to cell 
death [16-18].
In a healthy cell, the DNAs complex exists in an inactive state and 
comprises Caspase-activated DNA (CAD) and Inhibitory Caspase 
Activated DNA (ICAD). Caspase-3 cleaves ICAD from the CAD-
ICAD complex, there by initiating activity of DNAse, which promotes 
catabolism of nuclear DNA and chromatin resulting in decrease in 
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Figure 1:  Caspase cascade.
Figure showing overview of Caspase cascade which results in apoptosis. 
Initiator Caspases such as Caspases-2, -8, -9 and -10 activate downstream 
executer Caspases such as Caspases-3, -6 and -7, leading to decreased 
concentration of dopamine (shown by arrow downwards)and eventual 
apoptotic cell death.
Figure 2: Apoptotic events caused by Caspase-3.
Caspase-3 promotes formation of apoptotic bodies, increased fragmentation 
of DNA and decreased cell volume via breakdown of actin and fodrin, 
alongside activation of CAD, Caspases-6 and -7. The formation of apoptotic 
bodies, chromatin condensation and breakdown of the cell structure, leads to 
release of ROS which affects neighbouring cells, resulting in mass destruction 
of DCN and PD pathogenesis.
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cell volume and cell death [19,20] (Figure 2). Subsequently, other 
organelles such as Endoplasmic Reticulum (ER) and Golgi complex 
are degraded via Caspases by catabolism of Bap31(Bcl-2-interacting 
protein), a component of a protein complex in the endoplasmic 
reticulum alongside Golgi membrane proteins [21]. Moreover, the 
production of ROS during apoptosis promotes further destruction 
of nearby cells. ROS produced by the apoptotic cells attack the 
phospholipids bilayer components of adjacent cells, promoting 
the formation of pores. Subsequently, the ROS penetrate through 
the pores causing further destruction to the cell via proteolysis of 
essential proteins and nucleic acid, resulting in further cell death. A 
mass destruction of DCN caused by prolonged Caspase-activation 
may contribute to the onset of PD.
Involvement of the intrinsic (mitochondrial) pathway in 
death of DCN
One of the major pathways that results in Caspase activation is the 
mitochondrial/intrinsic pathway. The mitochondria play an essential 
role in ATP production, which is required for many cellular processes 
to take place. The mitochondrion is comprised of complexes1-5, which 
are part of the electron transport chain and embedded in the inner 
mitochondrial membrane. These complexes are needed to generate 
ATP. In addition, electron carriers, cytochrome C and coenzyme Q 
(ubiquinone) are also located in the inner mitochondrial membrane 
[22]. Cardiolipin is a negatively charged phospholipid located 
between the inner and outer membranes of the mitochondria. It 
links cytochrome C to the inner mitochondrial membrane. However, 
during oxidative stress, the cardiolipin acyl chains are oxidised, 
allowing the release of cytochrome C from the inner mitochondrial 
membrane and into the cytosol. In the presence of ATP, cytochrome 
C induces the zymogen, pro-Caspase-9 to bind to Apaf 1, leading 
to the activation of Caspase-9. Subsequently, Caspase-9 promotes 
Caspase-3 activation resulting in cell death [23].
Synaptic terminals have abundance of mitochondria, and 
mitochondrial fusion to mitochondrial fission ratio is essential in 
promoting optimal ATP levels and activity of the mitochondria. 
Preventing mitochondrion fission promotes enlarged size but reduced 
quantity of mitochondria, decreased oxidative phosphorylation, 
alongside increased levels of ROS and collapse of mitochondrial 
membrane potential [20]. Oxidative stress depletes ATP and NADH 
levels resulting in impairment of complex-I of the mitochondria. 
Malfunction of the mitochondria leads to defects in ubiquitination, 
which contributes to the activation of Caspases-1, -3 and -8 [24,25]. 
Subsequently, the mitochondria’s mPTP is opened and cytochrome 
C is released.
The mitochondrion is very susceptible to oxidative stress; the rise 
of ROS such as superoxides, hydroxyls and nitric oxide accumulating 
in DCN promote cleavage of DNA bases via extracting hydrogen atoms 
and thereby causing a shift in genetic sequence and the generation 
of mitochondrial mutated genes. Immunofluorescence analysis has 
shown degeneration of neurons and increase in Caspase activation 
in knock out PINK-1 in tunicamycin treated rat cortical neurons, 
indicating a strong link between ER stress, PINK-1 suppression 
and activation of Caspases [26]. In addition, the lack of histones in 
mitochondrial DNA, permit mitochondria to be more vulnerable to 
oxidative stress. The increased levels of hydrogen peroxide, leads to 
lipid peroxidation, whilst elevated levels of peroxynitrate result in 
DNA damage. Reduced levels of DNA polymerase was observed in 
PD animal model, suggesting suppression of DNA excision repair 
function [27-29].
Parkinson plays a vital role in maintaining mitochondrial 
homeostasis, alongside Unfolded Protein Response (UPR) in ER. 
Mutation of Parkin gene results in ER stress and/or oxidative 
stress induced cell death. Mutation in Parkin and PINK1 (PTEN-
induced putative kinase1) genes has been strongly associated with 
the progression of PD via mitochondrial-dependent cell apoptosis 
[28,30] (Figure 3).
A study conducted by Bender et al (2006) revealed the presence 
of higher levels of mitochondrial DNA deletions in PD patients 
when compared to the control [31]. DJ-1 is located in various tissues 
including brain and found in the matrix and Inner Membrane 
Space (IMS) of the mitochondria, DJ-1 functions as an antioxidant 
by reducing hydrogen peroxide levels. Frame shift and missense 
mutations, alongside deletions and insertions of DJ-1gene, contribute 
to early PD onset. Mutated DJ-1 leads to increase in oxidative stress 
and mitochondrial impairment, causing degeneration of DCN, 
resulting in development of PD [22,27,29](Figure 3).
LRRK2 (Leucine Rich Repeat Kinase2) also known as dardarin, 
is associated with nigrostriatal dopamine system, and is found in 
brain striatum and frontal cortex, located in the outer mitochondrial 
membrane and cytoplasm (Figure 3). A mutated variant of LRRK2, 
which is found in the outside of the mitochondrial membrane, 
Figure 3: The role of mutant mitochondrial genes  PD pathogenesis.
Figure showing the different mutated genes in relation to the mitochondria 
in PD pathogenesis. Oxidative stress promotes mutated DJ1 gene to travel 
from the cytoplasm to the IMS and to the mitochondrial matrix, where it 
allows production of ROS.   Mutated HTRA2 is translocated from the IMS 
to the cytoplasm where it promotes Caspase-meditated death of DCNs via 
apoptotic pathway. Mutated LRRK2 which is found in the outside of the 
mitochondrial membrane contributes to toxicity and death of neurons. PINK1 
gene is located in the Outer Mitochondrial Membrane (OMM) and IMM 
functions to decrease ROS levels and suppresses cytochromec. Mutations 
of PINK1 and Parkin allow production of ROS and release of cytochrome C, 
promoting death of cells via apoptotic route.
Austin Alzheimers J Parkinsons Dis 1(3): id1017 (2014)  - Page - 04
Ahmed BY Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
contributes to toxicity and death of neurons resulting in late onset of 
PD [22,27,29].
HTRA2 (High Temperature RequirementA2) is apro-apoptotic 
protease found in the IMS of the mitochondria, which plays a 
vital role in mitochondrial homeostasis. External stimuli such as 
environmental toxins, provoke HTRA2 gene to translocate from the 
IMS to the cytoplasm, promoting Caspase-meditated death of cells 
via apoptotic pathway. Over expression of HTRA2 in mice has shown 
severe loss of motor neurons via stimulation of the mitochondrial 
apoptotic pathway, resulting in symptoms similar to that of PD. 
Moreover, degeneration of striatal neurons caused by stimulation of 
Caspases has been observed in PD-induced mice [22,27,29] (Figure 
3).
Mitochondrial pathway can also be stimulated by activation of 
C-Jun N-Terminal Kinases (JNK), and p38 pathways. JNK is a group 
of Mitogen Activated Protein Kinases (MAPK) that play an essential 
role in apoptosis. Activation of JNK has been strongly associated with 
development of neurodegenerative disorders, particularly PD [32]. 
In the JNK pathway, cytochrome C promotes binding of Caspase-9 
to the JNK domain forming complexes that stimulate Caspase-9, 
which in turn cleaves and activates Caspase-3. Liou et al (2005) found 
that MPTP-induced toxicity caused activation of JNK and promoted 
stimulation of Caspase pathway in differentiated PC12 cells [14]. 
Chun et al (2001) demonstrated that MPTP and hydrogen peroxide 
induced stimulation of JNK pathway, which in turn provoked 
Caspase-1and Caspase-3 activation, resulting in apoptosis of clonal 
nigral dopaminergic cell line SN474 [33]. The study established that 
Caspase-1 plays a vital role in apoptosis of DCN. In the p38 pathway, 
cytochrome C promotes binding of the cytosolic protein, AIF to 
Caspase-9, forming a complex that permits activation of Caspase-9. 
Subsequently, Caspase-9 stimulates Caspase-3 activity resulting in 
apoptosis of DCN [34].
The substantial elevated amount of Caspase-2 observed at the 
early stage, indicated that Caspase-2 may also contribute to loss of 
DCN in the early phases of PD [35]. Active Caspase-2 promotes 
release of cytokines such as interleukin-6 and interleukin-8, leading 
to stimulation of microglia and death of neuronal cells via apoptotic 
routes. Oxidative stress, toxicity and mutations of specific genes, such 
as Parkin E3 ligase can damage the proteasome ubiquitin system 
resulting in elevated levels of aggregated mis-folded proteins, which 
accumulate to form Lewy bodies which are abnormal aggregates of 
protein that develop inside PD’s neurons forming one of the hallmark 
of the disease, bodies alongside stimulating activation of Caspase-12. 
Active Caspase-12 stimulates Caspase-9, which in turn results in 
motivation of Caspase-3. Active Caspase-3 promotes fragmentation 
of DNA, shrinkage cell, formation of apoptotic bodies and death of 
neuronal cells. The mass destruction of DCN causes degeneration of 
neurones, resulting in the development of PD (Figure 4).
Conclusion 
Caspase family including initiator and executioner Caspases play 
a vital role in inducing death of dopaminergic neurons, resulting 
in development and progression of PD. This review highlights the 
involvement of mitochondrial intrinsic pathway in which exposure 
to various stimuli such as oxidative stress, inflammation, genetic 
mutations and environmental toxins trigger the activation of 
Caspases which suggest their contribution to death of DCNs either by 
individual activation or via cascade reaction. Understanding the full 
mechanism of action of Caspase (s) may provide answers to whether 
using Caspases as a target for inhibition or could reduce cell death 
of DCN and therefore may aid in the development of potential new 
treatments for PD.
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Figure 4: Mitochondrial dysfunction activates Caspase pathways that lead to cell apoptosis resulting in the development of PD.
Figure illustrates the stimulation of various pathways such as oxidative stress, ER stress, and environmental toxins alongside genetic mutations followed by 
activation of JNK and P38 pathways along with impaired proteasome ubiquitin system causing mitochondrial dysfunction. Subsequently release of cytochrome C, 
leading to activation of Caspase cascade resulting in DCN death and progression of PD.
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